Sensei biotherapeutics to participate in oppenheimer's 33rd annual healthcare conference

Boston, march 06, 2023 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that company management will present at oppenheimer's 33rd annual healthcare conference. the presentation will be available at 8:00 a.m. et on monday, march 13th, 2023.
SNSE Ratings Summary
SNSE Quant Ranking